Nasdaq-listed Biotech Enlivex Therapeutics is raising $212 million for a late-cycle DAT play to initiate the first Nasdaq crypto treasury strategy based on a prediction market token.
More Nasdaq-listed Enlivex plans $212M RAIN token play with ex-Italian PM onboard Videos